Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of Recombinant HPV Bivalent Vaccine (Yeast) in Healthy Females
NCT02740790Phase 2Completed
- Sponsor
- Shanghai Zerun Biotechnology Co., Ltd.
- Start
- Sep 2013
- Primary completion
- Sep 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Walrinvax in human papillomavirus infection, sponsored by Shanghai Zerun Biotechnology Co., Ltd.. Started Sep 2013; status: completed.
02
Drugs
Walrinvax
03
Conditions
human papillomavirus infection
Beyond the preview
Go deeper on NCT02740790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02740790.